Bloomberg Markets & Finance via Youtube


Nov.18 — CureVac Chief Executive Officer Franz-Werner Haas discusses the progress on the biopharmaceutical company’s Covid-19 vaccine and scale-up for its production on “Bloomberg Surveillance.”

READ ALSO  SE: Economist Zentner Sees Slowing U.S. Job Growth Through Winter